Affiliation
Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London WC1V 6LJ, UK.Issue Date
2020
Metadata
Show full item recordCitation
James EC, McNeish IA, Cook AD, Kaplan R, Clamp AR. Progression-free survival in the ICON8 trial Authors' reply. Lancet. 2020;396(10253):757.Journal
LancetDOI
10.1016/s0140-6736(20)31177-6PubMed ID
32919511Additional Links
https://dx.doi.org/10.1016/s0140-6736(20)31177-6Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/s0140-6736(20)31177-6
Scopus Count
Collections
Related articles
- Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
- Authors: Morgan RD, McNeish IA, Cook AD, James EC, Lord R, Dark G, Glasspool RM, Krell J, Parkinson C, Poole CJ, Hall M, Gallardo-Rincón D, Lockley M, Essapen S, Summers J, Anand A, Zachariah A, Williams S, Jones R, Scatchard K, Walther A, Kim JW, Sundar S, Jayson GC, Ledermann JA, Clamp AR
- Issue date: 2021 Feb
- Progression-free survival in the ICON8 trial.
- Authors: Ludmir EB, McCaw ZR, Fuller CD, Wei LJ
- Issue date: 2020 Sep 12
- Progression-free survival in the ICON8 trial.
- Authors: Balieiro Anastacio da Costa AA, Baiocchi G, Guimarães APG
- Issue date: 2020 Sep 12
- Radiographic progression-free survival in the ACIS trial for prostate cancer - Authors' reply.
- Authors: Saad F, De Porre P, Brookman-May S, Li J, McCarthy SA, Rathkopf DE
- Issue date: 2022 Jan
- Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
- Authors: Clamp AR, James EC, McNeish IA, Dean A, Kim JW, O'Donnell DM, Gallardo-Rincon D, Blagden S, Brenton J, Perren TJ, Sundar S, Lord R, Dark G, Hall M, Banerjee S, Glasspool RM, Hanna CL, Williams S, Scatchard KM, Nam H, Essapen S, Parkinson C, McAvan L, Swart AM, Popoola B, Schiavone F, Badrock J, Fananapazir F, Cook AD, Parmar M, Kaplan R, Ledermann JA
- Issue date: 2022 Jul